openPR Logo
Press release

Lipid Disorder Treatment Market: Increase in Level of Triglyceride to Fuel Market Growth

11-28-2018 03:57 PM CET | Health & Medicine

Press release from: Transparency Market Research

Lipid Disorder Treatment Market: Increase in Level

Emergence of various lifestyle diseases has been witnessed worldwide, especially among teens and people lying in the 50-60 years age group. Lipid disorders are largely caused due to high cholesterol and triglycerides, which ultimately can result in increased chances of heart diseases, which has prompted the development of safe and efficient treatments for lipid disorders. Moreover, smoking and drinking have largely contributed to the rising prevalence of lipid disorders and other cardiovascular diseases among men and women. This has fuelled demand for advanced treatments such as introduction of modern lipid lowering drugs. The demand for lipid disorder treatments has risen owing to occupational diseases caused by higher consumption of alcohol results in rising amount of bad cholesterol or LDL, irregular eating habits, lack of body exercises and improper medication.

Read Report Overview @ https://www.transparencymarketresearch.com/lipid-disorder-treatment-market.html

Analysis of Transparency Market Research shows that the global market for lipid disorder treatment is expected to grow at an exceptional pace during the period of assessment. This growth is fuelled by rising demand for modern lipid metabolism disorder treatments coupled with increased chances of cardiovascular diseases across the globe. The global market for lipid disorder treatment is poised to register a value CAGR of 7.4% during the period of assessment, 2017-2026.

Several biopharma companies are focusing on developing effective solutions for treating lipid disorders. Companies involved in lipid disorder treatment market include Teva Pharmaceuticals, Mylan Pharmaceuticals, Inc., Kowa Pharmaceuticals America, Inc., Glenmark Pharmaceuticals Ltd., Sun Pharmaceuticals Industries Ltd., and Wockhardt Limited.

Request for the Sample Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=40640

Sales of Drugs to Treat Lipid Disorders to Remain High in North America

United States has registered a higher number of people acquiring lipid disorders, especially among adults. Growing consumption of drugs such as atorvastatin and fluvastatin to treat hypercholesterolemia and other associated lipid disorders has been witnessed in the country. Several tests have been performed to identify patients who have a high risk of developing lipid disorders owing to family history or genetic disorders. According to American Academy of Pediatrics and National Heart, Lung and Blood Institute, atherosclerotic cardiovascular disease is a leading cause of death in the region.

This has pushed the use of prescription drugs in the region, making it imperative for pharma companies to increase their production rate and revise their production cycles. In addition, screening for lipid disorders in childhood has been initiated in the region, and as per study, a moderate percentage of children population in the United States is being affected by lipid disorders, that typically surface as the child reaches its teenage. This has presented potential opportunities for sale of drugs for the treatment of lipid disorders in North America, making it an attractive region from a business point of view.

Obtain the Report Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=40640

Atorvastatin to Witness Increased Demand for Lipid Disorder Treatment

As the risk of developing lipid disorders increases, pharmaceutical companies have initiated drug enhancement, introduction of new drugs and conducting phase trials of these drugs on a large scale. Statins are considered to be highly effective in lowering the rate cardiovascular events. Most companies are focusing on mass production of atorvastatin as they are a highly effective low density lipoprotein lowering agents, LDL being the main cause of lipid disorders and associated heart diseases. The consumption of atorvastatin is expected to grow at a higher rate. Market for atorvastatin is poised to reach a value of over US$ 16 Bn by the end of the assessment period.

About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact Us

Transparency Market Research,
90 Sate Street, Suite 700,
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: https://www.transparencymarketresearch.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Lipid Disorder Treatment Market: Increase in Level of Triglyceride to Fuel Market Growth here

News-ID: 1405707 • Views: 180

More Releases from Transparency Market Research

Extracorporeal Co2 Removal Market Analysis Growth Drivers and Forecast 2018-2026 …
The global extracorporeal co2 removal market rides on the back of technology. As consumer focus shifts from access to comfort, players in the market for extracorporeal co2 removal are looking at new opportunities to capitalize on the potential. This exclusive report from Transparency Market Research will take you through an extensive analysis of every aspect in the extracorporeal co2 removal market that is critical for defining your success strategy. It
Cervical Dysplasia Market Emerging Technological Growth, Future Growth and Busin …
The global cervical dysplasia market rides on the back of technology. As consumer focus shifts from access to comfort, players in the market for cervical dysplasia are looking at new opportunities to capitalize on the potential. This exclusive report from Transparency Market Research will take you through an extensive analysis of every aspect in the cervical dysplasia market that is critical for defining your success strategy. It offers prudent information
Optical Microscopes Market Emerging Analysis, Future Growth and Business Opportu …
The global optical microscopes market rides on the back of technology. As consumer focus shifts from access to comfort, players in the market for optical microscopes are looking at new opportunities to capitalize on the potential. This exclusive report from Transparency Market Research will take you through an extensive analysis of every aspect in the optical microscopes market that is critical for defining your success strategy. It offers prudent information
Blood Transfusion Diagnostics Market Trends, Business Strategies and Opportuniti …
The global blood transfusion diagnostics market rides on the back of technology. As consumer focus shifts from access to comfort, players in the market for blood transfusion diagnostics are looking at new opportunities to capitalize on the potential. This exclusive report from Transparency Market Research will take you through an extensive analysis of every aspect in the blood transfusion diagnostics market that is critical for defining your success strategy. It

All 5 Releases


More Releases for Lipid

Lipid Analysis Devices Market – Regional Analysis
The lipid analysis devices are used for measuring elevated plasma cholesterol or triglycerides or low level of high-density lipoprotein (HDL). The determination of blood lipid levels is important for monitoring the risk of cardiovascular disease. Lipid analysis device is used for detection of hyperlipidemia, hypertriglyceridemia, hypercholesterolemia, hyperlipoproteinemia, and tangier disease. Lipid analysis device can be implemented at the clinics or it can be a point-of-care device. Point-of-care device has wider
Lipid Coated Bead Products - Exclusive Tools From Echelon for Protein-Lipid Inte …
MoBiTec's partner company Echelon Biosciences, USA, is excited to introduce a new class of lipid microparticles small enough to be used in phagocytosis experiments! Phosphatidylserine (PS), Phosphatidylcholine (PC), and PC/PS microparticles have phospholipids attached in a unique way allowing headgroups to be exposed and available for the study of biological interactions. Their size, approximately 3 µm, are ideal for phagocytosis and accommodates analysis with standard flow cytometry and microscopy methods. Lipid
Lipid Panel Test Market Estimated to Flourish by 2015 – 2023
Lipid Panel Test Market: Overview Anti-inflammatory peptides also known as antiflammins inhibit inflammation of a mammal’s skin, lacerations of the musculature, mucous membranes, or injury into the air spaces of the lungs. Anti-inflammatory peptides act by hindering synthesis of platelet-activating factor, neutrophil aggregation and chemotaxis, and intradermal inflammatory reactions. Anti-Inflammatory peptides are used to treat diseases such as psoriasis, multiple sclerosis, inflammatory bowel disease and other autoimmune diseases. Download PDF Brochure of
Lipid Analysis Devices Market – Regional Analysis
The lipid analysis devices are used for measuring elevated plasma cholesterol or triglycerides or low level of high-density lipoprotein (HDL). The determination of blood lipid levels is important for monitoring the risk of cardiovascular disease. Lipid analysis device is used for detection of hyperlipidemia, hypertriglyceridemia, hypercholesterolemia, hyperlipoproteinemia, and tangier disease. Lipid analysis device can be implemented at the clinics or it can be a point-of-care device. Point-of-care device has wider
Lipid Nutrition Market Growth with Worldwide Industry Analysis to 2025
Lipid Nutrition Market: Introduction: Lipid Nutrition is essential to fast required in our daily diet for proper functionality and metabolism of our body. The lipid nutrition market is composed of different types of fats with specific functionality and benefits of the human body. Also, lipid nutrition is also used in animal feed and pet food formulas to increase lipid contain the by products from the livestock and increase pet health. The
Asia-Pacific Lipid Market will Target Emerging Markets by 2022
In this report, the Asia-Pacific Lipid market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split Asia-Pacific into several key Regions, with sales (K MT), revenue (Million USD), market share and growth rate of Lipid for these regions, from 2012 to 2022 (forecast), including China Japan South Korea Taiwan India Southeast